Status:

RECRUITING

Effects of Voodoo Flossing Technique in Knee Osteoarthritis Patients

Lead Sponsor:

Riphah International University

Conditions:

Knee Osteoarthritis

Pain

Eligibility:

All Genders

45-65 years

Phase:

NA

Brief Summary

Knee osteoarthritis (KOA) is a prevalent degenerative joint disease characterized by pain, stiffness, and reduced physical function, significantly impacting quality of life especially in elderly popul...

Detailed Description

A double blinded randomized controlled trial has been conducted to investigate the effectiveness of integrating flossing band therapy with conventional physiotherapy, anticipating outcomes of pain red...

Eligibility Criteria

Inclusion

  • Age ≥ 45 and ≤ 65
  • Both Male and Female
  • Knee Pain persisting for at-least 3 months
  • Pain severity during walking ≥ 2/10 on a Numeric Pain Rating Scale
  • Walking and Balance (Mobility) problems according to Time Up \& Go (TUG) test
  • Poor scoring on WOMAC scale for pain, stiffness and physical activities
  • Knee OA Grade II (according to Kellgren-Lawrence method)
  • Participants must provide informed consent for participation in RCT

Exclusion

  • Age \< 45 and \> 65
  • Severe Knee pain during Walking ≥ 9/10 on a Numeric Pain Rating Scale
  • Knee OA Grade I, III \& IV (according to Kellgren-Lawrence method)
  • Physical or Mental co-morbidity severely affecting daily life of patient
  • Any Contraindication to provide Exercise Therapy
  • Suspicion of chronic widespread pain (i.e., pain present for at least 3 months in at least three joints including left and right side of the body, above and below the waist, and the axial skeleton)
  • Participant undergone total knee arthroplasty or on waiting list for total knee arthroplasty in any knee
  • Any other reasons for knee pain than knee OA (e.g., rheumatoid arthritis and gout)
  • Received intraarticular injections in past 6 months because of knee pain (Hyaluronic Gel or steroid)

Key Trial Info

Start Date :

June 12 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2025

Estimated Enrollment :

42 Patients enrolled

Trial Details

Trial ID

NCT06986694

Start Date

June 12 2025

End Date

December 1 2025

Last Update

July 4 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Horizon Hospital

Lahore, Punjab Province, Pakistan, 54782